Traders Buy High Volume of Evelo Biosciences Put Options (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLO) was the recipient of some unusual options trading activity on Wednesday. Stock investors bought 1,885 put options on the company. This is an increase of 1,101% compared to the typical daily volume of 157 put options.

Evelo Biosciences Price Performance

Shares of EVLO opened at $0.00 on Thursday. The stock has a market cap of $9,491.50, a price-to-earnings ratio of 0.00 and a beta of 0.83. Evelo Biosciences has a 12-month low of $0.00 and a 12-month high of $0.00.

Evelo Biosciences Company Profile

Evelo Biosciences, Inc, a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.